Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Cohn

Showing results (651-660 of 730) with videos related to

Pageof 73
Sort By:
Gynecologic Oncology|January 23, 2024
Does the choice of platinum doublet matter? A study to evaluate the impact of platinum doublet choice for treatment of platinum-sensitive ovarian cancer recurrence on the development of future PARP inhibitor and platinum resistanceMonica D Levine, Heather Wang, Bhargavi Sriram, et al.
Gynecologic Oncology|March 8, 2020
Is hormonal therapy after risk-reducing salpingo-oophorectomy associated with an increased risk of malignancy in pathogenic variant carriers?Kathryn A Mills, Tanvi V Joshi, Lindsay West, et al.
Neoplasia (New York, N.Y.)|August 21, 2020
Evaluating the efficacy of enzalutamide and the development of resistance in a preclinical mouse model of type-I endometrial carcinomaChristopher S Koivisto, Melodie Parrish, Santosh B Bonala, et al.
Obstetrics and Gynecology|May 2, 2007
Clinical and pathologic correlates in surgical stage II endometrial carcinomaDavid E Cohn, Emily M Woeste, Stacey Cacchio, et al.
The Journal of Infectious Diseases|January 15, 2013
Human immunodeficiency viruses appear compartmentalized to the female genital tract in cross-sectional analyses but genital lineages do not persist over timeMarta E Bull, Laura M Heath, Jennifer L McKernan-Mullin, et al.
Annals of Internal Medicine|October 3, 2000
Discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count. A randomized, double-blind, placebo-controlled trial. AIDS Clinical Trials Group 362 Study TeamJ S Currier, P L Williams, S L Koletar, et al.
Journal of Extracellular Biology|June 28, 2024
ISG15 mediates the function of extracellular vesicles in promoting ovarian cancer progression and metastasisKalpana Deepa Priya Dorayappan, Vincent Wagner, Dongju Park, et al.
Gynecologic Oncology|September 24, 2004
A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference?Teresa L Rutledge, Scott A Kamelle, Todd D Tillmanns, et al.
Surgical Oncology|September 6, 2020
Pathologic chemotherapy response score in epithelial ovarian cancer: Surgical, genetic, and survival considerationsDavid A Barrington, Ashley S Felix, Rieham Owda, et al.
Cells|April 27, 2026
Serum Extracellular Vesicle Protein Signatures Associated with Early-Stage High-Grade Serous Ovarian CarcinomaMichelle Lightfoot, Kalpana Deepa Priya Dorayappan, Vignesh Vudatha, et al.
Pageof 73

Showing results (651-660 of 730) with videos related to

Sort By:
Pageof 73
Gynecologic Oncology|January 23, 2024
Does the choice of platinum doublet matter? A study to evaluate the impact of platinum doublet choice for treatment of platinum-sensitive ovarian cancer recurrence on the development of future PARP inhibitor and platinum resistanceMonica D Levine, Heather Wang, Bhargavi Sriram, et al.
Gynecologic Oncology|March 8, 2020
Is hormonal therapy after risk-reducing salpingo-oophorectomy associated with an increased risk of malignancy in pathogenic variant carriers?Kathryn A Mills, Tanvi V Joshi, Lindsay West, et al.
Neoplasia (New York, N.Y.)|August 21, 2020
Evaluating the efficacy of enzalutamide and the development of resistance in a preclinical mouse model of type-I endometrial carcinomaChristopher S Koivisto, Melodie Parrish, Santosh B Bonala, et al.
Obstetrics and Gynecology|May 2, 2007
Clinical and pathologic correlates in surgical stage II endometrial carcinomaDavid E Cohn, Emily M Woeste, Stacey Cacchio, et al.
The Journal of Infectious Diseases|January 15, 2013
Human immunodeficiency viruses appear compartmentalized to the female genital tract in cross-sectional analyses but genital lineages do not persist over timeMarta E Bull, Laura M Heath, Jennifer L McKernan-Mullin, et al.
Annals of Internal Medicine|October 3, 2000
Discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count. A randomized, double-blind, placebo-controlled trial. AIDS Clinical Trials Group 362 Study TeamJ S Currier, P L Williams, S L Koletar, et al.
Journal of Extracellular Biology|June 28, 2024
ISG15 mediates the function of extracellular vesicles in promoting ovarian cancer progression and metastasisKalpana Deepa Priya Dorayappan, Vincent Wagner, Dongju Park, et al.
Gynecologic Oncology|September 24, 2004
A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference?Teresa L Rutledge, Scott A Kamelle, Todd D Tillmanns, et al.
Surgical Oncology|September 6, 2020
Pathologic chemotherapy response score in epithelial ovarian cancer: Surgical, genetic, and survival considerationsDavid A Barrington, Ashley S Felix, Rieham Owda, et al.
Cells|April 27, 2026
Serum Extracellular Vesicle Protein Signatures Associated with Early-Stage High-Grade Serous Ovarian CarcinomaMichelle Lightfoot, Kalpana Deepa Priya Dorayappan, Vignesh Vudatha, et al.
Pageof 73